The Institute of Cancer Research
This research position focuses on mapping microprotein interactions during bacterial infections using a dual prokaryotic-eukaryotic proteomics workflow and ribosome profiling. The role involves probing the functions of infection-induced microproteins, developing a discovery workflow, and collaborating across the ORFeus network to provide training data for computational models. The position includes a three-month secondment at Tesorai to refine AI-driven peptide-spectrum matching.
Headquarters
London, England, United Kingdom
Company Size
1001-5000 employees
Founded
1909
The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations, with an outstanding record of achievement.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for The Institute of Cancer Research.
88% above the average for this role
Project 12: Impact of genetic variation in regulatory translons on protein expression
Orfeus Research
Project 8: Predicting microprotein functionality through evolutionary analysis
Orfeus Research
Project 13: The Dark Proteome and Non-Canonical Translation in Cancer
Orfeus Research
Project 10: Mining the functional microproteome landscape using thermal proteome profiling (Petra Van Damme)
Ghent University
Proteomics Mass Spectrometrist
Eurofins
Project 11: Finding hidden HPV cancer antigens recognized by T cells
Orfeus Research